Contents of this document
- Increase in users accompanying new CS Set contracts
- Change from immediate expensing of Lifte to amortization over three years
- Year-on-year decrease in the number of Lifte installations
The company identifies the factors but does not state the amount attributable to each one.
- AssumptionsImpact of rising costsFiguresLimited as of Q2. From Q3 onward, medium to high impact expected for linen, medium impact for consumables, and high impact for disposable diapers
- AssumptionsPassing Through Price IncreasesFiguresSome impact from Q2, expected to become evident from Q3 onward
- Acquisition of new CS Set facilities
- Expansion of value-added services and new products
- Investment in new businesses and overseas operations
- Consideration of M&A
- Design of performance-linked stock options
- Number of contracted facilities at period-end2,942 FacilityYear on year against the same period last year+9.3%
- Cancellation rate excluding closures and other factors2.9 %
- Monthly users (average during the period)501,774 peopleYear on year against the same period last year+7.7%
- Facilities using CS Set R380 Facility
- Facilities using CS Set LC312 Facility
- Facilities using Lifte549 Facility
- Facilities using Smile Wear112 Facility
- Number of synergies realized with M3116 Engagements
| Item | Details |
|---|---|
| Document type | Presentation materials for financial results |
| Fiscal Period Covered | Second quarter of the fiscal year ending December 2026 |
| Net Sales | ¥29,525 million (YoY +10.0%) |
| Operating profit | ¥2,641 million (YoY +28.3%) |
| Ordinary income | ¥2,591 million (YoY +27.5%) |
| Net income | ¥1,738 million (YoY +27.2%) |
| Gross Profit Margin | 22.6 % |
| Operating profit margin | 8.9 % |
| Selling, general and administrative expenses | ¥4,040 million |
| Full-year earnings forecast | Net Sales ¥60,800 million / Operating profit ¥5,000 million / Ordinary income ¥5,000 million / Profit attributable to owners of the parent ¥3,200 million / EPS ¥52.81 |
| Segment results | Domestic Net Sales ¥28,694 million / Operating profit ¥2,622 million / Year on year against the same period last year Not disclosed / Overseas (Vietnam) Net Sales ¥831 million / Operating profit ¥18 million / Year on year against the same period last year Not disclosed |
| Breakdown of Factors Affecting the Change | Factors Increase in users accompanying new CS Set contracts / Amount Not disclosed, Factors Change from immediate expensing of Lifte to amortization over three years / Amount Not disclosed, Factors Year-on-year decrease in the number of Lifte installations / Amount Not disclosed |
| Key KPIs | Indicator name Number of contracted facilities at period-end / Value 2,942 Facility / Year on year against the same period last year 9.3 Facility, Indicator name Cancellation rate excluding closures and other factors / Value 2.9 % / Year on year against the same period last year Not disclosed, Indicator name Monthly users (average during the period) / Value 501,774 people / Year on year against the same period last year 7.7 people, Indicator name Facilities using CS Set R / Value 380 Facility / Year on year against the same period last year Not disclosed, Indicator name Facilities using CS Set LC / Value 312 Facility / Year on year against the same period last year Not disclosed, Indicator name Facilities using Lifte / Value 549 Facility / Year on year against the same period last year Not disclosed, Indicator name Facilities using Smile Wear / Value 112 Facility / Year on year against the same period last year Not disclosed, Indicator name Number of synergies realized with M3 / Value 116 Engagements / Year on year against the same period last year Not disclosed |
| Unit price and quantity metrics | Revenue per facility Not disclosed / Number of contracted facilities 2,942 / Monthly active users 501,774 |
| Number of employees | 1,498 People |
| Assumptions Underlying the Business Outlook | Assumptions Impact of rising costs / Figures Limited as of Q2. From Q3 onward, medium to high impact expected for linen, medium impact for consumables, and high impact for disposable diapers, Assumptions Passing Through Price Increases / Figures Some impact from Q2, expected to become evident from Q3 onward |
| Medium-term management plan targets | Net Sales 2026 608 Hundreds of millions of yen / 2028 800 Hundreds of millions of yen / Operating profit 2026 50 Hundreds of millions of yen / 2028 75 Hundreds of millions of yen / Operating profit margin 2026 8.2 % / 2028 9.4 % / ROE 2028 25 % |
| Financial targets | ROE 2025 actual 20.5 % / 2028 target 25 % / Cost of capital 7~8 |
| Annual Dividend | Annual Not disclosed / Interim Not disclosed / End of period ¥16 per share |
| Payout ratio | 30.3 |
| New initiatives | Acquisition of new CS Set facilities, Expansion of value-added services and new products, Investment in new businesses and overseas operations, Consideration of M&A, Design of performance-linked stock options |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The increase in revenue was primarily attributable to the increase in users accompanying 182 new CS Set contracts and 70 cancellations. The improvement in operating profit and gross profit margin was primarily attributable to changing the amortization method for Lifte (original patient garments) from immediate expensing to amortization over three years. The company explained that the effects of passing through higher prices began to emerge partially in the second quarter and are expected to become evident from the third quarter onward.